Boundless Bio, Inc. (BOLD)
Boundless Bio Market Cap: 28.65M for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CEL-SCI Corp. | 19.48M |
| AIM ImmunoTech, Inc. | 3.706M |
| IGC Pharma, Inc. | 28.16M |
| NovaBay Pharmaceuticals, Inc. | 707.83M |
| Protalix Biotherapeutics, Inc. | 168.88M |
Market Cap Related Metrics
| PEG Ratio | -0.9162 |
| Price to Book Value | 0.2601 |
| Price | 1.28 |
| Earnings Yield | -216.1% |
| PEGY Ratio | -0.9162 |